Postdoctoral Scientist for Liquid Biopsy of Cancer - Heidelberg, Deutschland - Deutsches Krebsforschungszentrum

Deutsches Krebsforschungszentrum

Geprüftes Unternehmen

Heidelberg, Deutschland

vor 3 Wochen

Geschrieben von:

Lena Wagner

beBee Recruiter

Beschreibung

Position:
Postdoctoral Scientist for Liquid Biopsy of Cancer**
Department: Cancer Genome Research

Code number:

The German Cancer Research Center is the largest biomedical research institution in Germany. With more than 3,000 employees, we operate an extensive scientific program in the field of cancer research.

The Division of Cancer Genome Research at DKFZ has a strong background in the analysis of genomic and epigenomic alterations in circulating DNA (cfDNA) and RNA from cancer patients (Angeles et al, 2022, 2023; Janke et al., In collaboration with partners at DKFZ, Heidelberg University and abroad, we use a broad spectrum of genomics and proteomics technologies to monitor tumor progression in samples from clinical studies.

To strengthen our team, we are looking for a postdoctoral scientist starting in April 2024.

Job description:

The division is a partner in several BMBF-funded cooperation projects investigating tumor heterogeneity in space and time.

Our role in these projects is the systematic analysis of longitudinal liquid biopsies (plasma) to monitor tumor heterogeneity and subclonal composition over time using state-of-the-art genomic and proteomic technologies.

References:

Angeles AK, Janke F, Daum AK, Reck M, Schneider MA, Thomas N, Christopoulos P, Sültmann H. Integrated circulating tumor DNA and cytokine analysis for therapy monitoring of ALK-rearranged lung adenocarcinoma. Brit J Cancer 129(1):112-121; Apr 29.

doi:
/s , 2023

Janke F, Angeles AK, Riediger AL, Bauer S, Reck M, Schneider MA, Muley T, Thomas M, Christopoulos P, Sültmann H.

Monitoring progression of ALK-rearranged lung adenocarcinoma using DNA methylation patterns in cell free DNA. Clinical Epigenetics, 14(1):163;

doi:
/s , 2022

Angeles AK*, Christopoulos P*, Yuan Z, Bauer S, Janke F, Ogrodnik SJ, Reck M, Schlesner M, Meister M, Schneider MA, Dietz S, Stenzinger A, Thomas M, Sültmann H.

Early identification of disease progression in ALK-rearranged lung cancer using circulating tumor DNA analysis. NPJ Precision Oncology, 5(1):100; DOI /s , 2021

Requirements:

PhD in biology, biochemistry, bioinformatics or related fields
Interest in performing translational research using stateoftheart technologies
Top level command of written and spoken English
Highly motivated team player with excellent communication skills

We offer:

Interesting, versatile workplace
Excellent framework conditions: stateoftheart equipment and opportunity for international networking at the highest level
Remuneration according to TV-L incl. occupational pension plan for the public service and capitalforming payments
30 days of vacation per year
Flexible working hours
Possibility of mobile work and parttime work
Familyfriendly working environment, including parentchild room, counseling services, e.g. on Elder Care
Sustainable travel to work: subsidized Germany job ticket
Develop your full potential: access to the DKFZ International Postdoc Program and DKFZ Career Service with targeted offers for your personal development to further develop your talents
Our Corporate Health Management Program offers a holistic approach to your wellbeing

Important notice:

Earliest possible start date:

Duration:
The position is initially limited to 2 years with the possibility of prolongation.

Application deadline:

Contact:

Prof. Dr. Holger Sültmann
Phone /56-5934

The DKFZ is committed to increase the proportion of women in all areas and positions in which women are underrepresented.

Qualified female applicants are therefore particularly encouraged to apply.